Notably, about 9 out of 10 individuals with obesity lost weight while taking tirzepatide. Excitement and anticipation surrounding SURMOUNT-1 have continued to grow since Eli Lilly and Company announced topline results of the trial in a release on April 28
International Journal of Molecular Sciences Discover personalized health & wellness treatments Alan Resource Center Get the most out of Alan Health with these resources
Check with your doctor before using it if you have diabetes or high blood pressure
Statistical analysis For statistical analysis of serum proteomics, we used Excel application (Microsoft, Redmond, WA, USA)
GLP-1s are also intended to be taken long-term
Int J Cardiol 292:218224 Dunning BE, Foley JE, Ahrn B (2005) Alpha cell function in health and disease: influence of glucagon-like peptide-1